Jean‐Claude Chomel

3.3k total citations
75 papers, 1.8k citations indexed

About

Jean‐Claude Chomel is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Jean‐Claude Chomel has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 45 papers in Genetics and 20 papers in Rheumatology. Recurrent topics in Jean‐Claude Chomel's work include Chronic Myeloid Leukemia Treatments (48 papers), Chronic Lymphocytic Leukemia Research (35 papers) and Eosinophilic Disorders and Syndromes (18 papers). Jean‐Claude Chomel is often cited by papers focused on Chronic Myeloid Leukemia Treatments (48 papers), Chronic Lymphocytic Leukemia Research (35 papers) and Eosinophilic Disorders and Syndromes (18 papers). Jean‐Claude Chomel collaborates with scholars based in France, United States and Canada. Jean‐Claude Chomel's co-authors include Alain Kitzis, Ali G. Turhan, A. Haliassos, François Guilhot, J.‐C. Kaplan, J Kruh, Nathalie Sorel, Laurent Tesson, Annelise Bennaceur‐Griscelli and Marie‐Laure Bonnet and has published in prestigious journals such as Nucleic Acids Research, Blood and Cancer.

In The Last Decade

Jean‐Claude Chomel

75 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Claude Chomel France 22 774 672 619 305 271 75 1.8k
Mitsuoki Eguchi Japan 21 878 1.1× 578 0.9× 330 0.5× 166 0.5× 110 0.4× 105 1.8k
Toshiaki Yujiri Japan 21 573 0.7× 954 1.4× 159 0.3× 360 1.2× 85 0.3× 72 2.2k
Giovanni Morrone Italy 26 499 0.6× 1.1k 1.6× 177 0.3× 471 1.5× 73 0.3× 58 2.1k
Franca Citarella Italy 23 289 0.4× 823 1.2× 514 0.8× 232 0.8× 137 0.5× 38 1.7k
Robert S. Welner United States 27 767 1.0× 861 1.3× 252 0.4× 328 1.1× 60 0.2× 85 2.2k
Alison A. Bertuch United States 27 343 0.4× 1.4k 2.1× 206 0.3× 209 0.7× 59 0.2× 77 2.2k
Tetsuya Yamagata Japan 25 618 0.8× 1.2k 1.8× 228 0.4× 499 1.6× 117 0.4× 58 2.7k
John Marken United States 9 587 0.8× 607 0.9× 135 0.2× 294 1.0× 135 0.5× 13 1.5k
Irina Golovleva Sweden 25 355 0.5× 927 1.4× 153 0.2× 225 0.7× 56 0.2× 78 1.9k
Masatsugu Ohta Japan 20 375 0.5× 930 1.4× 113 0.2× 337 1.1× 70 0.3× 49 1.6k

Countries citing papers authored by Jean‐Claude Chomel

Since Specialization
Citations

This map shows the geographic impact of Jean‐Claude Chomel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Chomel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Chomel more than expected).

Fields of papers citing papers by Jean‐Claude Chomel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Claude Chomel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Chomel. The network helps show where Jean‐Claude Chomel may publish in the future.

Co-authorship network of co-authors of Jean‐Claude Chomel

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Claude Chomel. A scholar is included among the top collaborators of Jean‐Claude Chomel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Claude Chomel. Jean‐Claude Chomel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chomel, Jean‐Claude, et al.. (2023). Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms. British Journal of Haematology. 202(2). 284–288. 3 indexed citations
2.
Desterke, Christophe, Paul Marcoux, Yücel Erbilgin, et al.. (2023). Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs). Cells. 12(4). 598–598. 5 indexed citations
3.
Sorel, Nathalie, Christophe Desterke, Émilie Cayssials, et al.. (2023). Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. International Journal of Molecular Sciences. 24(20). 15441–15441. 4 indexed citations
4.
Suárez, Felipe, et al.. (2021). Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection. Journal of Clinical Immunology. 42(1). 60–63. 5 indexed citations
5.
Turhan, Ali G., Nathalie Sorel, Christophe Desterke, et al.. (2020). Evidence of BCR-ABL1 -positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML). Leukemia & lymphoma. 61(7). 1719–1723. 3 indexed citations
6.
Sorel, Nathalie, Marie‐Laure Bonnet, Jean‐Michel Goujon, et al.. (2017). Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs). Leukemia Research. 60. 94–102. 20 indexed citations
7.
Sorel, Nathalie, Émilie Cayssials, Françoise Brizard, & Jean‐Claude Chomel. (2017). Treatment and molecular monitoring update in chronic myeloid leukemia management. Annales de biologie clinique. 75(2). 129–145. 7 indexed citations
8.
Dkhissi, Fatima, Julien Pontis, Nathalie Sorel, et al.. (2015). The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia. Experimental Hematology. 43(9). 775–780. 14 indexed citations
9.
Levescot, Anaïs, Stéphane Flamant, Florence Jacomet, et al.. (2014). BCR-ABL–Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia Patients. Cancer Research. 74(10). 2669–2676. 41 indexed citations
10.
Martin‐Lannerée, Severine, Imen Najjar, Isabelle Plo, et al.. (2013). Differential Contributions of STAT5A and STAT5B to Stress Protection and Tyrosine Kinase Inhibitor Resistance of Chronic Myeloid Leukemia Stem/Progenitor Cells. Cancer Research. 73(7). 2052–2058. 57 indexed citations
11.
Griscelli, Frank, Olivier Féraud, Noufϊssa Oudrhiri, et al.. (2012). Malignant Germ Cell–Like Tumors, Expressing Ki-1 Antigen (CD30), Are Revealed during in Vivo Differentiation of Partially Reprogrammed Human-Induced Pluripotent Stem Cells. American Journal Of Pathology. 180(5). 2084–2096. 24 indexed citations
12.
Chomel, Jean‐Claude & Ali G. Turhan. (2011). Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy. Oncotarget. 2(9). 713–727. 61 indexed citations
13.
Flamant, Stéphane, William Ritchie, Joëlle Guilhot, et al.. (2010). Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica. 95(8). 1325–1333. 91 indexed citations
14.
Sorel, Nathalie, Caroline Mayeur‐Rousse, Lydia Roy, et al.. (2010). Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia. Journal of Molecular Diagnostics. 12(4). 520–524. 9 indexed citations
15.
Chomel, Jean‐Claude, Nathalie Sorel, Caroline Mayeur‐Rousse, & Ali G. Turhan. (2009). Les syndromes myéloprolifératifs. Immuno-analyse & Biologie Spécialisée. 24(2). 69–85. 1 indexed citations
16.
17.
Ayrault, Olivier, Nathalie Sorel, Paule Seité, et al.. (2006). Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia. Leukemia Research. 30(10). 1273–1278. 2 indexed citations
18.
Bilan, Frédéric, et al.. (2004). Characterization of the Different BCR-ABL Transcripts with a Single Multiplex RT-PCR. Journal of Molecular Diagnostics. 6(4). 343–347. 30 indexed citations
19.
20.
Dahéron, Laurence, et al.. (1994). Evaluation of bone marrow transplantation efficiency by competitive PCR on Y sequences.. Genome Research. 3(6). 361–364. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuoki Eguchi Breakdown of academic impact, for papers by Toshiaki Yujiri Breakdown of academic impact, for papers by Giovanni Morrone Breakdown of academic impact, for papers by Franca Citarella Breakdown of academic impact, for papers by Robert S. Welner Breakdown of academic impact, for papers by Alison A. Bertuch Breakdown of academic impact, for papers by Tetsuya Yamagata Breakdown of academic impact, for papers by John Marken Breakdown of academic impact, for papers by Irina Golovleva Breakdown of academic impact, for papers by Masatsugu Ohta
Rankless by CCL
2026